JIMENEZ FREDDY A. (SVP & General Counsel) sold 2.2% of their position (771.00 shares) of CELLDEX THERAPEUTICS, INC. on the open market
Open‑market sale worth $19.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/15/2025ACC: 0001415889-25-022069
Officer· SVP & General Counsel
Since Jan 2021
-771.00
Net shares
Net seller
$19.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
771.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−341.00
Price / share
$23.95
Trade value
$8.17K
% of position
1.0%
8/13/2025
35.73K→35.39K
Common Stock
Direct
Shares
−430.00
Price / share
$25.41
Trade value
$10.93K
% of position
1.2%
8/13/2025
35.39K→34.96K
Total
Net shares
−771.00
Net value
-$19.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2025 | S · Sale | −341.00 | $23.95 | $8.17K | 1.0% | 35.73K | 35.39K |
| Common Stock Direct | 8/13/2025 | S · Sale | −430.00 | $25.41 | $10.93K | 1.2% | 35.39K | 34.96K |
| Total | −771.00 | -$19.10K | ||||||
Derivative Transactions0
No derivative transactions reported